{
  "Disease": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: Niacin extended - release / lovastatin is a new combination product approved for treatment of primary hypercholesterolemia and mixed dyslipidemia ."},
    {"role": "assistant", "content": "Based on the given paragraph, the identified \"Disease\" entity is:\n\n- Primary hypercholesterolemia\n- Mixed dyslipidemia"},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "Based on the given paragraph, the relevant \"Disease\" entity is:\n\n- Primary hypercholesterolemia"},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease                  |\n|--------------------------|\n| Primary hypercholesterolemia |"}
  ],
  "Chemical": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph.\n\nParagraph: Niacin extended - release / lovastatin is a new combination product approved for treatment of primary hypercholesterolemia and mixed dyslipidemia ."},
    {"role": "assistant", "content": "Based on the given paragraph, the identified \"Chemical\" entities are:\n\n| Chemical Entity |\n|-----------------|\n| Niacin          |\n| lovastatin      |"},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Chemical."},
    {"role": "assistant", "content": "Based on the given paragraph, the relevant \"Chemical\" entities are:\n\n| Chemical Entity |\n|-----------------|\n| Niacin          |\n| lovastatin      |"},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical         |\n|------------------|\n| Niacin           |\n| lovastatin       |"}
  ]
}